Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in Days.
The item "Defensive-Intrval-Ratio" stands at 287.72 days as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Defensive Intrval Ratio" stands at 287.72 Days. This represents an increase of 22.80 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -18.56 percent compared to the value the year prior.
The 1 year change in percent is -18.56.
The 3 year change in percent is -33.08.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Defensive Intrval Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Defensive Intrval Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Defensive Intrval Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Defensive Intrval Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Defensive Intrval Ratio | 280,205,508,085.11 |